Serotonin transporter (SERT) is responsible for reuptake and recycling of 5-hydroxytryptamine (5-HT; serotonin) after its exocytotic release during neurotransmission. Mutations in human SERT are associated with psychiatric disorders and autism. Some of these mutations affect the regulation of SERT activity by cGMPdependent phosphorylation. Here we provide direct evidence that this phosphorylation occurs at Thr276, predicted to lie near the cytoplasmic end of transmembrane helix 5 (TM5). Using membranes from HeLa cells expressing SERT and intact rat basophilic leukemia cells, we show that agents such as Na + and cocaine that stabilize outward-open conformations of SERT decreased phosphorylation and agents that stabilize inward-open conformations (e.g., 5-HT, ibogaine) increased phosphorylation. The opposing effects of the inhibitors cocaine and ibogaine were each reversed by an excess of the other inhibitor. Inhibition of phosphorylation by Na + and stimulation by ibogaine occurred at concentrations that induced outward opening and inward opening, respectively, as measured by the accessibility of cysteine residues in the extracellular and cytoplasmic permeation pathways, respectively. The results are consistent with a mechanism of SERT regulation that is activated by the transport of 5-HT, which increases the level of inward-open SERT and may lead to unwinding of the TM5 helix to allow phosphorylation.
Serotonin transporter (SERT) is responsible for reuptake and recycling of 5-hydroxytryptamine (5-HT; serotonin) after its exocytotic release during neurotransmission. Mutations in human SERT are associated with psychiatric disorders and autism. Some of these mutations affect the regulation of SERT activity by cGMPdependent phosphorylation. Here we provide direct evidence that this phosphorylation occurs at Thr276, predicted to lie near the cytoplasmic end of transmembrane helix 5 (TM5). Using membranes from HeLa cells expressing SERT and intact rat basophilic leukemia cells, we show that agents such as Na + and cocaine that stabilize outward-open conformations of SERT decreased phosphorylation and agents that stabilize inward-open conformations (e.g., 5-HT, ibogaine) increased phosphorylation. The opposing effects of the inhibitors cocaine and ibogaine were each reversed by an excess of the other inhibitor. Inhibition of phosphorylation by Na + and stimulation by ibogaine occurred at concentrations that induced outward opening and inward opening, respectively, as measured by the accessibility of cysteine residues in the extracellular and cytoplasmic permeation pathways, respectively. The results are consistent with a mechanism of SERT regulation that is activated by the transport of 5-HT, which increases the level of inward-open SERT and may lead to unwinding of the TM5 helix to allow phosphorylation. (1) reported a rare missense mutation in the coding region of serotonin transporter (SERT) in two unrelated families. Within these families, individuals with the mutation (Ile425Val, or I425V) were more strongly affected with several psychiatric disorders, including obsessive-compulsive disorder and autism spectrum disorders. Subsequently, additional families with this mutation and others in SERT have been identified (2) (3) (4) (5) (6) (7) (8) .
In transfected cells, the I425V mutation led to enhanced 5-HT transport relative to WT SERT (5, 9) . The enhanced transport was similar to the up-regulation of 5-HT transport that had been observed in rat basophilic leukemia (RBL-2H3) cells on stimulation of adenosine A3 receptors with subsequent NO formation and cGMP production (10) . Results with heterologously expressed SERT suggest that the I425V mutation interferes with this pathway either by directly increasing basal SERT phosphorylation or by inhibiting SERT dephosphorylation (11) .
Mutation of serine and threonine residues on the cytoplasmic surface of SERT led to the identification of Thr276 as a potential cGMP-dependent phosphorylation site (12) . From homology models based on prokaryotic and eukaryotic homologs, this residue is located near the cytoplasmic end of transmembrane helix 5 (TM5), a location that agrees with cysteine scanning accessibility studies (13) that also have shown this position to be poorly accessible to aqueous reagents. The unlikely location of a phosphorylation site in a transmembrane helix, and the inaccessibility of this position, cast some doubt on the proposal that Thr276 is the site of cGMP-stimulated phosphorylation. A possible mechanism for phosphorylation of SERT at this site is that the cytoplasmic end of the TM5 helix undergoes a conformational change in which the region containing Thr276 unwinds and extends into the cytoplasm, where it would be accessible to a kinase. A recent X-ray structure of the bacterial SERT homolog, MhsT, showed a partial unwinding of the cytoplasmic half of TM5 (14) , suggesting that such a conformational change might be possible.
Here we present additional support for Thr276 as the site of cGMP-stimulated SERT phosphorylation and examine the relationship between this phosphorylation and SERT conformational states. The results suggest a novel mechanism by which the normal function of SERT as a transporter acts to enhance its phosphorylation.
Materials and Methods
Materials. HeLa and RBL-2H3 cells were obtained from American Type Culture Collection. Rabbit polyclonal antibody against a rat SERT peptide containing phospho-Thr276 (p1700-276) was obtained from PhosphoSolutions. Rabbit polyclonal antibody against the human SERT C terminus (C-20) was a generous gift from Dr. F. Kilic, University of Arkansas, Little Rock, AR. Antibody against the γ-subunit of the Fce receptor (06-727) was obtained from Millipore. 2-Aminoethyl methane thiosulfonate hydrobromide (MTSEA) and (2-sulfonatoethyl) methanethiosulfonate (MTSES) were purchased from Anatrace. 8-(4-Chlorophenylthio)-guanosine 3′,5′-cyclic monophosphorothioate, Rp isomer (Rp-8-pCPT-cGMPS), S-nitroso-N-acetyl-DL-penicillamine (SNAP), 5′-(N-ethylcarboxamido)adenosine (NECA), 8-bromoguanosine-3′,5′-cyclic monophosphate (8-Br-cGMP), monoclonal anti-FLAG M2 affinity agarose, and 3×FLAG peptide were purchased from Sigma-Aldrich. Protein kinase G (PKG)-specific peptide substrate (RKRSRAE) was obtained from GenScript. Ni-NTA agarose was obtained from Qiagen. SERT mutants were generated using the QuikChange Site-Directed Mutagenesis Kit (Stratagene). N-terminal His 6 and C-terminal FLAG-tagged human SERT expression constructs were generated by PCR. In brief, forward and reverse primers containing unique restriction sites were designed to Significance Mutations in serotonin transporter (SERT) affecting regulation of a cGMP-dependent signaling pathway have been associated with psychiatric disorders. Earlier studies provided preliminary evidence that cGMP stimulates phosphorylation of SERT in a transmembrane helix. Transporters like SERT function by undergoing a cycle of conformational changes as they move their substrate (in this case the neurotransmitter 5-HT) across the membrane. This work shows that SERT conformation dramatically affects phosphorylation, which is stimulated when the transporter is in a conformation known to increase during 5-HT transport. The results suggest a novel mechanism of regulation in which transport of 5-HT increases the level of an inwardopen SERT conformation that provides accessibility of the phosphorylation site to a kinase.
introduce DNA sequences encoding six His residues immediately after the initiator methionine and a FLAG sequence immediately before the stop codon and used to amplify a full-length SERT. The PCR products were then digested with restriction enzymes, excised from agarose gels, and ligated into pcDNA3.1. The regions amplified by PCR were confirmed by DNA sequencing. Double-tagged SERT (His-SERT-FLAG) did not differ in transport rate or kinetics from WT SERT.
Cell Culture and Transfection. HeLa cells were cultured in DMEM supplemented with 10% (vol/vol) FBS, 2 mM L-glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin and RBL-2H3 in MEM with 15% (vol/vol) FBS, 100 U/mL penicillin, and 100 μg/mL streptomycin at 37°C in a humidified 5% (vol/vol) CO 2 incubator. SERT was expressed in HeLa cells transfected using lipofectin with pcDNA3.1 containing His-SERT-FLAG cDNA under control of the CMV promoter. Transfected cells were incubated for 24-36 h at 37°C with 5% (vol/vol) CO 2 before the transport assays. Protein concentration was determined using the Pierce Micro BCA Protein Assay Reagent Kit (Thermo Fisher Scientific).
Transport and Binding Assays. 5-HT transport into RBL cells or SERT-transfected HeLa cells was measured as described previously (13 Transport and phosphorylation were measured in intact HeLa cells, and using membranes from HeLa cells, expressing the indicated mutants, where the amino acid shown replaced the native threonine at position 276. Transport and phosphorylation were measured as described in Materials and Methods. ND, not determined. Results are from three or four experiments for phosphorylation and transport measurements, respectively, and uncertainties are SEs. Relative to WT (threonine), stimulation of both transport and phosphorylation was significantly decreased (P < 2 ×10 −4 ) for all amino acid replacements except serine, and the serine mutant was not significantly different from WT (P > 0.6). 33 P]ATP and purified PKG-1α in the absence or presence of 8-Br-cGMP at 30°C for 30 min and then solubilized. SERT was captured by anti-FLAG agarose, eluted with FLAG peptide, and subsequently subjected to the second purification using Ni-NTA agarose after denaturation with 8 M urea. The 300 mM imidazole eluate was resolved by SDS/PAGE, and radiolabeled SERT was detected by phosphorimaging. (B) Western blot analysis of in vivo phosphorylation with anti-SERT pThr276. HeLa cells were transfected with cDNAs encoding hSERT (WT or T276A) and PKG-1α and then treated with 8-Br-cGMP at 37°C for 30 min as indicated. SERT was solubilized and successively purified using anti-FLAG and Ni-NTA agarose. After treatment with PNGase F at 4°C overnight, phosphorylated SERT was detected by immunoblotting with anti-SERT pThr276. The results shown in the bar graphs represent band density of radiolabeled SERT or SERT recognized by anti-SERT pThr276, respectively, from three or two independent experiments, respectively, for After three washes with ice-cold 150 mM NaCl containing 25 mM Tris buffer, pH 8.0, 1 mM EDTA, 8 M urea, and 30 mM imidazole, SERT was eluted with 50 μL of 150 mM NaCl containing 25 mM Tris buffer, pH 8.0, 1 mM EDTA, 8 M urea, and 250 mM imidazole. A small portion of the eluate was counted with a Beckman LS6500 liquid scintillation counter, and the remainder was resolved by SDS/PAGE, and radiolabeled SERT was detected and quantified using a PharosFX Molecular Imager (Bio-Rad). To normalize for sample size, a parallel sample was subjected to immunoblot analysis using anti-SERT antibody, as described previously (16) .
8-Br
Biotinylation and Immunoblotting. Surface expression of SERT in RBL-2H3 was determined using the membrane-impermeant biotinylation reagent sulfo-NHS-SS-biotin (Thermo Fisher Scientific) as described previously for HeLa cells (13) . In brief, RBL cells were incubated twice with sulfo-NHS-SS-biotin for 20 min on ice. After labeling, the cells were rinsed with 100 mM glycine in PBS/ CM for 20 min on ice to quench excess reagent. The cells were then lysed, and biotinylated proteins were recovered using streptavidin-agarose beads (Thermo Fisher Scientific) in an overnight incubation at 4°C with gentle agitation. The beads were washed, and the biotinylated proteins were eluted with 50 μL of SDS/PAGE sample buffer. The eluate was applied to a 4-15% (wt/vol) gradient SDS-polyacrylamide gel and visualized by Western blot analysis. SERT phosphorylated at Thr-276 was detected using a rabbit polyclonal anti-SERT pThr276 (1:1,000). For total surface SERT expression, the blot was stripped with Restore Western Blot Stripping Buffer (Thermo Fisher Scientific) and reprobed with anti-SERT (C-term) antibody. Anti-γ-subunit of Fce receptor antibody as a loading control was detected on a separate blot using a reduced amount of sample. An IRDye 680RD donkey anti-rabbit IgG (LI-COR; 1:10,000) was used to visualize the signal, which was determined by quantitative fluorescence imaging using the LI-COR Odyssey CLx Infrared Imaging System. Accessibility Measurements. Conformational changes were measured using the accessibility of cysteine residues placed in the cytoplasmic (S277C) and extracellular (S404C) permeation pathways as described previously (17) . For measurement of extracellular pathway accessibility, intact cells expressing SERT C109A-S404C growing in 96-well plates were incubated for 15 min with 0.01 mM MTSEA and then washed with PBS/CM. Transport rates were then measured to determine the reactivity of S404C under the experimental conditions tested. For cytoplasmic pathway accessibility, membranes prepared from cells expressing SERT S277C-X5C were incubated on glass fiber filters for 15 min with 0.015 mM MTSEA and then washed with PBS/CM. The background construct, SERT X5C (C15A/C21A/C109A/C357A/C622A) (18) , was designed to have minimal reactivity toward MTSEA. In this construct, five reactive Cys residues were replaced with alanine to decrease sensitivity MTSEA sensitivity relative to WT SERT. Binding of the high-affinity cocaine analog β-CIT was measured on the filters as described previously (13) . Modification of Cys277 inactivates β-CIT binding by preventing closure of the cytoplasmic pathway and opening of the extracellular pathway (19) .
Data Analysis. Nonlinear regression fits of experimental and calculated data were performed with Origin software (OriginLab), which uses the Marquardt-Levenberg nonlinear least squares curve-fitting algorithm. The statistical analysis given was from multiple experiments. Data with error bars represent the mean ± SE for multiple experiments. Statistical analyses comparing control and experimental conditions were performed using Student's paired t test.
Results PKG Activation Stimulates SERT Phosphorylation at Thr276. Whereas mutation of SERT Thr276 to Ala abolishes PKG-dependent regulation of transport, direct evidence for phosphorylation of Thr276 has been lacking. To examine the characteristics of Thr276 as a phosphorylation site in SERT, we mutated this residue to alanine, serine, glycine, cysteine, aspartate, and glutamate, and tested the ability of these SERT mutants to respond to PKG activation by an increase in transport activity, phosphorylation, or both. The results, shown in Table 1 , indicate that of the tested amino acid replacements, only serine was able to substitute for the , and 8-Br-cGMP (100 μM) in buffer containing 150 mM NaCl or NMDG-Cl, as indicated. SERT was then subjected to two-step purification and resolved by SDS/PAGE, and radiolabeled SERT was detected by phosphorimaging as described in Materials and Methods. The results represent the relative integrated density of radiolabeled SERT from four independent experiments (mean ± SEM). Asterisks indicate statistically significant (P < 0.015) changes in integrated density of radiolabeled SERT compared with the sodium control (dashed line).
native threonine. Although these results are consistent with the action of a serine/threonine kinase at Thr/Ser276, they do not rule out the possibility that a β-hydroxy amino acid is required in this position to allow phosphorylation at other positions. Consequently, we used an antibody raised against a SERT peptide containing phospho-Thr276.
As shown in Fig. 1A , using membranes from HeLa cells expressing FLAG-tagged WT SERT, purified PKG-Iα stimulated SERT phosphorylation from [γ-
33 P]-ATP in the presence of cGMP. FLAG-tagged SERT T276A was not phosphorylated under the same conditions. The anti-SERT pThr276 antibody labeled SERT in Western blots from parallel incubations with unlabeled ATP when WT SERT was phosphorylated in the presence of cGMP, but not in the case of the T276A mutant (Fig.  1B) . These results provide further evidence that Thr276 is the site of phosphorylation in response to PKG activation.
Because HeLa cells do not endogenously express SERT, and the results in Table 1 and Fig. 1 were obtained using an in vitro phosphorylation assay dependent on added PKG, we tested the ability of anti-SERT pThr276 to detect phosphorylation in RBL-2H3, a neurosecretory cell line that endogenously expresses SERT and all cellular components required for its phosphorylation in response to activation of adenosine A3 receptors on the cell surface. Treatment of RBL cells with the A3 agonist NECA, the NO donor SNAP, or 8-Br-cGMP led to an increase in phosphorylation as measured by reactivity toward anti-SERT pThr276 in Western blots (Fig. 2) . 5-HT transport into the treated cells was increased as well (Fig. 2) . The effect of each stimulus on both transport and phosphorylation was blocked by the PKG inhibitor Rp-8pCPT-cGMPS, indicating that each of these agents stimulates SERT transport and phosphorylation through activation of PKG.
Stimulation of SERT activity by cGMP signaling in RBL cells and synaptosomes has been suggested to result from either an increase in SERT abundance on the cell surface (20) or an increase in catalytic efficiency (12) . We examined the level of SERT cell surface expression in RBL and its response to NECA, SNAP, and cGMP. We determined surface expression by biotinylating surface proteins with the impermeant reagent sulfo-NHS-biotin, extracting labeled proteins using streptavidin agarose, and performing Western blot analysis with a C-terminal SERT antibody and, as an internal control, an antibody against the Fce receptor γ-subunit. These treatments, which increased 5-HT transport activity and the level of SERT phosphorylation, did not induce a corresponding increase in surface expression. These results are consistent with a signaling pathway starting with the activation of A3 receptors, leading to production of NO by NOS, subsequent activation of guanylyl cyclase, and the action of cGMP on PKG, as originally proposed by Miller and Hoffman (10) . Moreover, they indicate that SERT phosphorylation increases catalytic activity without an increase in SERT surface localization. Our previous results showed that PKG does not directly phosphorylate SERT, implicating the action of an unidentified kinase and potentially additional signaling components downstream from PKG (15) .
Agents that Affect SERT Conformation Influence PKG-Dependent Phosphorylation. To examine the effects of SERT conformation on PKG-dependent phosphorylation, we measured the phosphorylation of exogenously expressed SERT in purified membrane preparations in vitro with [γ- 33 P]ATP as in Fig. 1A . Although added PKG is required for SERT phosphorylation under these conditions, our previous results indicate that PKG does not directly phosphorylate the transporter. Phosphorylation was determined under conditions that influence the distribution of SERT between inwardopen and outward-open conformations. Na + is known to stabilize SERT and other transporters in the NSS family in outward-open conformations (21) (22) (23) (24) (25) . Fig. 3 shows that Na + inhibited cGMP and PKG-dependent Thr276 phosphorylation to approximately onehalf of the level found in the absence of Na + , with NMDG used as a substitute cation. Cocaine, which also stabilizes outward-open conformations, further decreased phosphorylation in the presence of Na + (Fig. 3) . In contrast, ibogaine, a noncompetitive SERT inhibitor that stabilizes inward-open conformations (17, 26, 27) , dramatically increased Thr276 phosphorylation in the presence of Na + (Fig. 3) . 5-HT, the substrate for SERT, stimulated conversion PKG activity against the peptide substrate (RKRSRAE) was determined in the presence of the indicated concentrations of various agents as described previously (15) of the transporter to inward-open conformations (19, 27, 28) and also stimulated phosphorylation, although not as strongly as ibogaine (Fig. 3) . The effects of Na + , cocaine, ibogaine, and 5-HT on SERT phosphorylation could not be attributed to a direct effect on PKG. We measured in vitro phosphorylation of the PKG-specific peptide substrate RKRSRAE by purified PKG Iα with [γ- 33 P]ATP as the phosphate donor. Na + , 5-HT, and SERT inhibitors, (cocaine, ibogaine) had minimal effects on PKG activity (Table 2) .
We tested the influence of SERT conformation on Thr276 phosphorylation in RBL cells to confirm that the effects were preserved in an intact cell system in which all components of the cGMP signaling pathway are endogenously expressed. This experiment used reactivity of anti-SERT pThr276 as an indicator of phosphorylation. The results in Fig. 4 show that 8-Br-cGMP modestly, but significantly increased SERT Thr276 phosphorylation in RBL cells in Na + medium (Fig. 4 , leftmost two columns). The phosphorylation level was further increased by ibogaine and 5-HT or replacement of Na + by NMDG, and was inhibited by cocaine. We noticed an elevated basal level of phosphorylation in RBL cells (Fig. 4) relative to in vitro studies with SERT expressed in HeLa cell membranes (Figs. 1 and 3 ). Prolonged incubation with 10 μM Rp-8-pCPT-cGMPS or 10 μM 1H- [1, 2, 4] oxadiazolo [4,3-a] quinoxalin-1-one, a highly selective irreversible inhibitor of soluble guanylyl cyclase, did not decrease SERT phosphorylation in RBL cells below the level seen with Na + buffer. These results suggest that PKG does not mediate basal phosphorylation of SERT in these cells, and imply the existence of one or more additional pathways leading to SERT Thr276 phosphorylation.
Cocaine and ibogaine compete for sites on SERT that are mutually exclusive (17, 26, 27) . This competition is also apparent in the opposing effects of these drugs on PKG-induced SERT phosphorylation in vitro. Ibogaine (4 μM) was sufficient to increase phosphorylation by fivefold in the presence of 150 mM NaCl. The addition of cocaine antagonized this increase, with half-maximal inhibition occurring at concentrations <2 μM (Fig.  5A) . Conversely, 5 μM cocaine was sufficient to inhibit phosphorylation by almost 90% in the absence of Na + . This inhibition was reversed by ibogaine, with half-maximal stimulation at <20 μM (Fig. 5B) . These results support the idea that the competitive influence of cocaine and ibogaine on transporter conformation led to competitive antagonism in their effects on phosphorylation. Na + , cocaine, ibogaine, and 5-HT are all known to influence SERT distribution between outward-open and inward-open states. Nevertheless, the experimental results described above do not rule out the possibility that other proteins in the cGMPdependent signaling pathway leading to SERT phosphorylation could be sensitive to these agents and might mediate their effects. Accordingly, we compared the ability of Na + and ibogaine to influence SERT conformation with their effect on PKGinduced phosphorylation in isolated membranes (Fig. 6) . Conformation was measured by the reactivity of cysteine residues introduced at sites in the extracellular or cytoplasmic permeation pathways. In intact cells, we measured the accessibility of a cysteine residue at position 404 in the extracellular pathway. The solid line in Fig. 6A shows the extent of modification by the aqueous reagent MTSEA at varying [Na + ], as measured by inactivation of 5-HT transport. The dashed line shows the influence of Na + on phosphorylation under the same conditions. In conformational responses to Na + and ibogaine were remarkably similar to those of phosphorylation (Fig. 6 ). These observations are consistent with the proposal that SERT conformation controls PKG-dependent phosphorylation at Thr276.
To evaluate the effect of NaCl and ibogaine on the region of TM5 surrounding T276, we measured the rate constant for inactivation of SERT mutants by MTSES. The results, illustrated in Fig. 7 , show that G273C, with a cysteine residue in the second intracellular loop, and S277C react fairly rapidly with this cysteine reagent. Cysteine replacements of V274 through T276 were much less reactive, as was V278C. The reactivity of most of these mutants was increased by 20 μM ibogaine or by replacement of NaCl with NMDG-SO 4 ; however, the increase was similar through this region, and the helical pattern of reactivity was not measurably altered by these treatments.
Discussion
The principal conclusion that can be drawn from our results is that SERT is more susceptible to cGMP-stimulated phosphorylation at Thr276 when in an inward-facing, as opposed to an outward-facing conformation. Because SERT shuttles between such conformations when transporting 5-HT across the membrane, this conclusion has direct implications concerning the effect of 5-HT transport on the phosphorylation process and its consequences for SERT activity.
In the absence of extracellular 5-HT, SERT is likely to be in an outward-facing conformation. The presence of extracellular Na + stabilizes outward-facing states of SERT (24), and the subsequent addition of 5-HT leads to a synchronous conformational change associated with a transient current (28) . By analogy with prokaryotic SERT homologs, this substrate-dependent change represents opening of a cytoplasmic substrate permeation pathway (21, 29) that also has been observed with SERT (19) and leads to a release of substrate to the cytoplasm. Subsequently, SERT returns to an outward-facing conformation in a K + -stimulated step that is rate-limiting for transport (28, 30) . Because the transition from inward-facing to outward-facing conformations is the slow step in the transport cycle, SERT will accumulate in an inward-facing conformation when transporting 5-HT. Thus, SERT is more likely to be in an outward-facing conformation in the absence of 5-HT and in an inward-facing conformation in the presence of 5-HT.
The consequence of cGMP-dependent SERT phosphorylation is to increase SERT activity. This increase has been proposed to result from either increased catalytic activity (9, 12) or increased expression of SERT on the cell surface (31) . The data in Fig. 2 show that stimulation of cGMP signaling increased SERT transport and phosphorylation in RBL cells with little effect on surface expression. Moreover, Table 3 clearly shows that SERT surface expression in RBL cells was not affected by 8-Br-cGMP alone or by agents (i.e., Na + , 5-HT, cocaine, or ibogaine) that modified its effect on SERT phosphorylation. These results suggest that the increase in SERT activity associated with cGMPstimulated phosphorylation results from an increase in the transport activity of SERT molecules preexisting on the cell surface. We do not yet understand the mechanism by which phosphorylation of Thr276 increases transport activity, but TM5, which is the likely location of this residue, lines the substrate permeation pathway, which opens and closes during the transport cycle, and its modification is likely to alter conformational dynamics of the transporter. Fig. 2 also shows that phosphorylation stimulated by an adenosine A3 receptor agonist, an NO donor, or by 8-Br-cGMP was inhibited in each case by the PKG inhibitor Rp-8-pCPTcGMPS, implicating PKG activation as a key step in the phosphorylation process. The results are consistent with A3 receptor activation leading to activation of nNOS, presumably through increased cytosolic Ca 2+ levels. The resulting NO would stimulate soluble guanylyl cyclase to produce cGMP, thereby activating PKG, as proposed by Miller and Hoffman (10) . Our previous work showed that PKG does not directly phosphorylate SERT and that an additional, unidentified kinase is responsible (15) . The significant level of basal SERT phosphorylation in RBL cells, shown in Figs. 2 and 4 , was insensitive to the inhibition of cGMP signaling. These observations may result from another pathway leading to SERT phosphorylation that is independent of cGMP signaling and may converge with the cGMP pathway at the level of the unidentified SERT kinase.
Both in vitro and in RBL cells, ibogaine was more effective than 5-HT in stimulating phosphorylation. We can only speculate on the basis of this difference. However, at concentrations that saturate the transport rate, 5 Measurements of SERT surface expression in RBL cells were made as in Fig.  2 and described in Materials and Methods. The indicated reagents were used at the following concentrations: 8-Br-cGMP, 10 μM; ibogaine, 20 μM; cocaine, 5 μM; 5-HT, 1 μM. In the Na + -free sample, NMDG was used to replace 150 mM Na The effect of SERT conformation on cGMP-dependent phosphorylation suggests a novel role for this process in the control of 5-HT homeostasis. An increase in serotonergic neurotransmission will produce more extracellular 5-HT in terminals and varicosities where 5-HT is released. As the primary substrate for SERT, 5-HT converts the transporter from an outward-facing to an inwardfacing conformation, increasing its availability to serve as a substrate for phosphorylation, as shown in Figs. 3 and 4 in assays in vitro and in intact RBL cells. The increased activity of phosphorylated SERT allows more rapid reuptake of released 5-HT, potentially compensating for the increased release.
Another unique aspect of this signaling process comes from the mechanism by which SERT conformation controls phosphorylation. The phosphorylation site was proposed to be Thr276, and data presented in Table 1 and Fig. 1 provide additional evidence confirming this site. However, evidence suggests that this residue is in a relatively inaccessible position in TM5 (13, 26) , where it would seem unlikely to serve as a kinase substrate. Structural analysis of more than a dozen kinase-substrate complexes has repeatedly shown that peptide substrates bind in an extended conformation (32, 33) , unlike the helical structure that we identified for the region of SERT TM5 containing Thr276 (13) . TM5 is also one of the helices lining the permeation pathway by which 5-HT and ions are delivered to the cytoplasm, however (19) , and as such, its accessibility to solvent increases dramatically in inward-facing conformations. The homologous bacterial transporter MhsT was recently crystallized in an inward-occluded conformation in which the cytoplasmic half of TM5 had lost considerable helical character between Gly171 and Pro181 (14) , which are conserved as Gly278 and Pro288 in SERT. Thus, a probable mechanism for Thr276 phosphorylation emerges in which unwinding of the TM5 helix in inward-facing conformations allows the sequence containing Thr276 to extend into the cytoplasm, where it can be phosphorylated.
Although phosphorylation sites typically fall within unstructured regions and exposed loops (34) , the requirement for a conformational change to facilitate accessibility to a phosphorylation site has been observed occasionally in other systems. For example, Ser51, the regulatory phosphorylation site in eukaryotic initiation factor 2α (eIF2α), is sequestered within an α-helix, but interaction with its kinase PKR promotes melting of the helix to allow access to the phosphoacceptor residue (35, 36) . Similarly, bifunctional isocitrate dehydrogenase kinase/phosphatases in bacteria appear to induce a conformational rearrangement in their substrates that liberates a phosphorylation site residue that is normally buried and thus inaccessible (37) . In these cases, the presence of the phosphorylation site in a folded helix serves as a mechanism for achieving a high degree of specificity for a particular phosphorylating kinase. In contrast, conformational rearrangement of SERT leading to exposure of its phosphorylation site is facilitated by substrate binding and translocation, potentially as a mechanism to promote SERT activity in the presence of substrate. Ibogaine and NaCl removal increased MTSES reactivity in this region (Fig. 7) , and interaction with the SERT Thr276 kinase also may contribute to an unwinding of the helix to facilitate phosphorylation. However, the overall pattern of accessibility did not change as accessibility increased (Fig. 7) , suggesting that helix unwinding affects only a small fraction of SERT at any given time.
Because SERT mutations, such as I425V, that affect cGMPdependent phosphorylation are associated with several psychiatric disorders, it seems likely that this signaling pathway plays an important role in 5-HT homeostasis in vivo. The knowledge that agents controlling SERT conformation can modulate cGMP signaling provides potential ways to manipulate the pathway pharmacologically. For example, SERT-selective compounds that act like ibogaine could enhance SERT phosphorylation, and inhibitors of the as-yet unidentified kinase that phosphorylates SERT at Thr276 could be used to inhibit the process. Because SERT is the target of so many therapeutic drugs, all of which are competitive inhibitors that stabilize outward-facing conformations, it may be worth considering agents that influence the function of SERT by favoring alternative conformations that enhance cGMP-dependent phosphorylation.
